Clinical Trials Directory

Trials / Completed

CompletedNCT02311816

Increase in Procalcitonin Kinetics May be a Good Indicator of Starting Empirical Antibiotic Treatment in Critically Ill Patients

Status
Completed
Phase
Study type
Observational
Enrollment
114 (actual)
Sponsor
Domonkos Trásy · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The value of procalcitonin change from the day before to the day when infection was suspected in predicting bacterial infection in intensive care patients.

Detailed description

Starting antibiotic therapy early in critically ill patients with suspected infection is of utmost importance with significant effect on survival. Procalcitonin is a reliable sepsis marker but results about its usefulness in initiating antimicrobials are conflicting. Our aim is to investigate the predictive value of 24 hours procalcitonin kinetics before starting empirical antibiotic therapy in intensive care patients as an indicator of the presence of bacterial infection.

Conditions

Timeline

Start date
2012-10-01
Primary completion
2013-10-01
Completion
2013-10-01
First posted
2014-12-08
Last updated
2014-12-08

Locations

1 site across 1 country: Hungary

Source: ClinicalTrials.gov record NCT02311816. Inclusion in this directory is not an endorsement.